Cardiovascular disease — risk assessment and reduction: NICE 2023 update for GPs.

The National Institute for Health and Care Excellence (NICE) has updated its guidelines on preventing cardiovascular disease, particularly focusing on lipid management. The new guidance expands the range of patients eligible for lipid-lowering therapy based on lifetime risk of cardiovascular disease. While statins are the first-line treatment, the guidance emphasizes patient-centered care and individualized treatment, with lifestyle interventions recommended alongside medication. The update may lead to increased workload for GPs but aims to reduce future cardiovascular events and improve population health. [Extracted from the article]